Dynavax Technologies News
Most Popular Dynavax Technologies Story
Dynavax forges development deal with GSK
Dynavax Technologies has landed a $10 million upfront payment and up to $200 million in milestones for each of four development programs optioned by GlaxoSmithKline. Glaxo gets an exclusive option... Read more...
Latest Headlines
- January 26, 2010
- September 9, 2009
- December 17, 2008
- August 6, 2008
- April 17, 2008
- March 18, 2008
- November 1, 2007
- July 19, 2007
- December 3, 2006
- November 28, 2006
- November 7, 2006
- September 6, 2006
- August 20, 2006
- April 19, 2006
- January 18, 2006
- June 13, 2005
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
